QLOSI Drug Patent Profile

✉ Email this page to a colleague

When do Qlosi patents expire, and what generic alternatives are available?

Qlosi is a drug marketed by Orasis Pharms and is included in one NDA. There are four patents protecting this drug.

This drug has twenty-four patent family members in fourteen countries.

The generic ingredient in QLOSI is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Qlosi

A generic version of QLOSI was approved as pilocarpine hydrochloride by PADAGIS US on November 16^th, 2004.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for QLOSI?
What are the global sales for QLOSI?
What is Average Wholesale Price for QLOSI?

Summary for QLOSI

International Patents:	24
US Patents:	4
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
What excipients (inactive ingredients) are in QLOSI?	QLOSI excipients list
DailyMed Link:	QLOSI at DailyMed

Drug patent expirations by year for QLOSI

Pharmacology for QLOSI

Drug Class	Cholinergic Receptor Agonist
Mechanism of Action	Cholinergic Agonists Cholinergic Muscarinic Agonists

US Patents and Regulatory Information for QLOSI

QLOSI is protected by four US patents and one FDA Regulatory Exclusivity.

Patents protecting QLOSI

Ophthalmic pharmaceutical compositions and uses relating thereto
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PRESBYOPIA

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PRESBYOPIA

Ophthalmic pharmaceutical compositions and uses relating thereto
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PRESBYOPIA

FDA Regulatory Exclusivity protecting QLOSI

NEW PRODUCT
Exclusivity Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for QLOSI

See the table below for patents covering QLOSI around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Mexico	2019001877	COMPOSICIONES FARMACEUTICAS OFTALMICAS Y USOS QUE SE RELACIONAN A LAS MISMAS. (OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO.)	⤷ Sign Up
Israel	264664		⤷ Sign Up
China	116726006	眼科药物组合物及其相关用途 (Ophthalmic pharmaceutical compositions and uses related thereto)	⤷ Sign Up
Japan	2019524826	眼科用医薬組成物及びそれに関する使用	⤷ Sign Up
Australia	2017311636	Ophthalmic pharmaceutical compositions and uses relating thereto	⤷ Sign Up
South Korea	102588499		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration